Preferred Label : diphosphonates;

MeSH definition : Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents.;

MeSH synonym : bisphosphonates; Bisphosphonate;

Wikipedia link : https://en.wikipedia.org/wiki/Bisphosphonate;

Is substance : O;

Details


Main resources

You can consult :

Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents.

http://www.has-sante.fr/portail/jcms/c_1751307/fr/les-medicaments-de-losteoporose
2023
false
true
false
France
French
bone density conservation agents
osteoporosis
treatment outcome
alendronic acid
alendronate
guidelines for drug use
zoledronic acid
administration, oral
risedronic acid
denosumab
Raloxifene Hydrochloride
strontium ranelate
strontium ranelate
teriparatide
teriparatide
spinal fractures
hip fractures
costs and cost analysis
bone density conservation agents
drug costs
bone density
risk
osteoporosis, postmenopausal
adrenal cortex hormones
osteoporosis
osteoporotic fractures
alendronic acid and colecalciferol
drugs, generic
infusions, intravenous
risedronic acid, calcium and colecalciferol, sequential
injections, subcutaneous
raloxifene
algorithms
Adrenocortical steroid therapy
corticosteroid therapy
Risedronic Acid
Denosumab
diphosphonates
imidazoles
organometallic compounds
thiophenes
Zoledronic Acid

---
https://www.cbip.be/fr/articles/3759?folia=3757
2022
false
false
false
Belgium
French
journal article
administration, oral
cholinergic antagonists
eye diseases
diphosphonates
amiodarone
hydroxychloroquine
phenothiazines
glucocorticoids

---
Medikamentöse Osteoporose-therapie: Behandlungsdauer und Vorgehen nach Therapieende
https://smf.swisshealthweb.ch/fr/article/doi/fms.2017.03062/
10.4414/fms.2017.03062
2017
false
false
false
Switzerland
French
German
journal article
osteoporosis, postmenopausal
diphosphonates
bisphosphonates
Denosumab
practice guidelines as topic
denosumab
bone density conservation agents
rank ligand
comparative effectiveness research
teriparatide
teriparatide
Duration of treatment (qualifier value)
osteoporotic fractures
treatment outcome
spinal fractures
guidelines for drug use
bone density
risk
vitamin D
hip fractures
Rebound effect
Therapy cessation
Tumor Necrosis Factor Inhibitors

---
http://www.oiiq.org/sites/default/files/uploads/periodiques/Perspective/vol13no01/13-pratique-clinique.pdf
2016
false
false
false
false
Canada
French
journal article
osteoporotic fractures
case reports
risk assessment
osteoporotic fractures
osteoporotic fractures
diphosphonates
bone density conservation agents
adult
absorptiometry, photon
osteoporotic fractures
dietary supplements
osteoporotic fractures

---
http://www.has-sante.fr/portail/jcms/c_2621683/fr/aclasta
2016
true
France
French
osteitis deformans
treatment outcome
male osteoporosis
osteoporosis, postmenopausal
osteoporosis
bone density conservation agents
diphosphonates
imidazoles
injections, intravenous
zoledronic acid
evaluation of the transparency committee
Zoledronic Acid

---
http://www.sudoc.fr/197078125
2016
false
true
false
France
French
dissertations, academic
treaties
case histories
institutionalization
femur
femoral fractures
therapeutics
bone density conservation agents
data collection
residential facilities
institutionalization
hip fractures
femur
extremities
fractures, bone
femoral fractures
guideline adherence
diphosphonates
international cooperation
case reports

---
https://minerva-ebp.be/FR/Article/2052
2016
false
false
false
false
Belgium
French
critical appraisal or critical reading
breast neoplasms
neoplasm metastasis
bone neoplasms
menopause
diphosphonates
chemotherapy, adjuvant
treatment outcome
breast neoplasms
Metastatic Malignant Neoplasm in the Bone
neoplasm recurrence, local
comparative study

---
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-12-fra.php#bisp
2016
false
false
false
Canada
French
English
drug evaluation
administration, oral
diphosphonates
risk assessment
bone density conservation agents
Bisphosphonate-Associated osteonecrosis of the jaw
infusions, intravenous

---
http://www.has-sante.fr/portail/jcms/c_2734084/fr/osteogenese-imparfaite
2016
false
false
false
France
French
practice guideline
osteogenesis imperfecta
general practice
osteogenesis imperfecta
diagnosis, differential
osteogenesis imperfecta
child
adult
disease management
pregnancy
osteogenesis imperfecta
diphosphonates
watchful waiting
osteogenesis imperfecta
general practitioners

---
http://www.cochrane.org/fr/CD010750/les-traitements-medicamenteux-de-la-douleur-chez-les-enfants-et-les-jeunes-atteints-dune-maladie
2015
false
false
false
Switzerland
United Kingdom
French
pain
adolescent
child
french abstract
life expectancy
cerebral palsy
osteogenesis imperfecta
baclofen
botulinum toxins, type A
treatment outcome
diphosphonates
review of literature

---
http://www.mbcb-journal.org/articles/mbcb/abs/2013/01/mbcb120049/mbcb120049.html
2015
false
false
false
France
French
journal article
Bisphosphonate-Associated osteonecrosis of the jaw
diphosphonates
risk factors
Bisphosphonate-Associated osteonecrosis of the jaw
incidence

---
http://www.has-sante.fr/portail/jcms/c_2038292/fr/bondronat
http://www.has-sante.fr/portail/jcms/c_1020505/bondronat
http://www.has-sante.fr/portail/jcms/c_400002/fr/bondronat-6-mg/6ml-solution-a-diluer-pour-perfusion-boite-de-1-et-boite-de-5
2015
false
true
false
France
French
evaluation of the transparency committee
ibandronic acid
insurance, health, reimbursement
treatment outcome
bone neoplasms
breast neoplasms
neoplasm metastasis
Pathologic Fracture
bone neoplasms
bone neoplasms
Pathologic fracture of bone at site of metastatic neoplasm (disorder)
bone density conservation agents
diphosphonates
Ibandronic Acid

---
http://www.meddispar.fr/Medicaments/ACIDE-ZOLEDRONIQUE-KABI-4-B-1/(type)/letter/(value)/A/(cip)/3400926699543
2014
false
true
false
France
French
drug information
zoledronic acid
drugs, generic
drug prescriptions
legislation, drug
infusions, intravenous
continuity of patient care
drug monitoring
diphosphonates
imidazoles
Zoledronic Acid

---
http://www.meddispar.fr/Medicaments/ACIDE-ZOLEDRONIQUE-TEVA-PHARMA-5-B-1/(type)/letter/(value)/A/(cip)/3400926883775
2014
false
false
false
France
French
drug information
zoledronic acid
soil
soil
diphosphonates
imidazoles
Zoledronic Acid

---
http://www.cfp.ca/content/60/4/e197.full
2014
Canada
French
osteoporosis
diphosphonates
journal article
osteoporotic fractures
case reports
bone density conservation agents
diphosphates
bone density conservation agents
Bisphosphonate-Associated osteonecrosis of the jaw
femoral fractures
retreatment
drug administration schedule
Therapy cessation

---
https://www.ema.europa.eu/medicines/human/EPAR/Zoledronic-Acid-Accord
2014
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
zoledronic acid
adult
drugs, generic
bone density conservation agents
bone density conservation agents
bone neoplasms
fractures, bone
spinal cord compression
hypercalcemia
infusions, intravenous
neoplasms
aged
drug interactions
renal insufficiency
pregnancy
breast feeding
fertility
drug evaluation, preclinical
diphosphonates
imidazoles
diphosphonates
imidazoles
Zoledronic Acid
Zoledronic Acid

---
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_Portrait_usage_osteoporose.pdf
2014
false
false
false
Canada
French
technical report
adult
aged
diphosphonates
osteoporotic fractures
alendronate
bone density conservation agents
imidazoles
medication adherence
vitamin D
calcium
calcium, dietary
osteoporosis
Risedronic Acid
Denosumab
Zoledronic Acid

---
https://www.revmed.ch/RMS/2013/RMS-390/Les-OS-des-personnes-infectees-par-le-VIH-sont-ils-si-fragiles
2013
false
false
false
Switzerland
French
journal article
hiv infections
bone density
osteoporosis
bone diseases, metabolic
anti-retroviral agents
hiv infections
diphosphonates
Frailty (finding)

---
http://www.lecrat.eu/?s=Acide+tiludronique
2013
France
French
pregnancy
diphosphonates
bone density conservation agents
tiludronic acid
tiludronic acid
tiludronate disodium
diphosphonates
drug information

---
https://www.ema.europa.eu/medicines/human/EPAR/Zometa
2013
United Kingdom
English
French
syndication feed
drug evaluation
diphosphonates
imidazoles
bone density conservation agents
hypercalcemia
bone neoplasms
treatment outcome
imidazoles
diphosphonates
bone density conservation agents
bone resorption
zoledronic acid
diphosphonates
neoplasms
drug evaluation
summary of product characteristics
package leaflet
fractures, spontaneous
spinal cord compression
hypercalcemia
Zoledronic Acid

---
http://www.has-sante.fr/portail/jcms/c_1701315/fr/zometa
http://www.has-sante.fr/portail/jcms/c_1701314/fr/zometa06112013avisct12958
http://www.has-sante.fr/portail/jcms/c_981921/fr/zometa
http://www.has-sante.fr/portail/jcms/c_399784/fr/zometa-4-mg-poudre-et-solvant-pour-solution-pour-perfusion-boite-de-1
http://www.has-sante.fr/portail/jcms/c_399290/fr/zometa-4-mg-poudre-et-solvant-pour-solution-pour-perfusion-boite-de-1-4-et-10?xtmc=&xtcr=4
2013
France
French
evaluation of the transparency committee
bone density conservation agents
diphosphonates
imidazoles
zoledronic acid
infusions, intravenous
insurance, health, reimbursement
neoplasms
hypercalcemia
adult
bone neoplasms
bone neoplasms
fractures, spontaneous
spinal cord compression
Zoledronic Acid

---
http://kce.fgov.be/fr/publication/report/th%C3%A9rapies-de-soutien-en-cas-de-cancer-partie-3-traitement-de-la-douleur-pratiques
https://kce.fgov.be/sites/default/files/2021-11/KCE_211Bs_douleur_cancer_resume.pdf
2013
false
Belgium
French
Adrenocortical steroid therapy
corticosteroid therapy
Cancer Pain Management
Cancer Pain
Cancer pain
pain management
neoplasms
practice guideline
pain measurement
pain
french abstract
anti-inflammatory agents, non-steroidal
acetaminophen
analgesics, opioid
adrenal cortex hormones
pain
antidepressive agents
diphosphonates
bone neoplasms
bone neoplasms
bone neoplasms
neoplasm metastasis
neoplasm metastasis
radioisotopes
SKELETAL PAIN
anticonvulsants
celiac plexus
nerve block

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/897
2013
false
Canada
French
Denosumab
journal article
patient dropouts
administration, oral
osteoporosis
osteoporotic fractures
diphosphonates
Raloxifene Hydrochloride
selective estrogen receptor modulators
bone density conservation agents
raloxifene
teriparatide
teriparatide
calcitonin
calcitonin preparations
rank ligand
Tumor Necrosis Factor Inhibitors

---
http://www.cochrane.org/fr/CD002010
2013
United Kingdom
France
French
meta-analysis
cystic fibrosis
diphosphonates
osteoporosis
treatment outcome
bone density conservation agents
french abstract

---
http://www.edimark.fr/lettre-rhumatologue/osteoporose-bisphosphonates-osteonecrose-machoire-risque-perception-risque
2013
false
true
false
France
French
journal article
osteoporosis
Bisphosphonate-Associated osteonecrosis of the jaw
diphosphonates
risk factors
osteoporotic fractures

---
https://www.ema.europa.eu/medicines/human/EPAR/Iasibon
2012
United Kingdom
French
English
syndication feed
diphosphonates
diphosphonates
diphosphonates
drug approval
treatment outcome
infusions, intravenous
administration, oral
drugs, generic
bone density conservation agents
bone density conservation agents
hypercalcemia
bone neoplasms
fractures, bone
breast neoplasms
neoplasm metastasis
ibandronic acid
drug interactions
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
Ibandronic Acid
Ibandronic Acid

---
https://www.ema.europa.eu/medicines/human/EPAR/Ibandronic-acid-Accord
2012
United Kingdom
English
French
ibandronic acid
drug approval
europe
treatment outcome
summary of product characteristics
package leaflet
drug evaluation
syndication feed
infusions, intravenous
drugs, generic
bone neoplasms
breast neoplasms
neoplasm metastasis
fractures, bone
hypercalcemia
diphosphonates
diphosphonates
bone density conservation agents
bone density conservation agents
neoplasms
adult
aged
drug interactions
pregnancy
breast feeding
fertility
bone resorption
drug evaluation, preclinical
Ibandronic Acid
Ibandronic Acid

---
http://www.cochrane.org/fr/CD003188
2012
false
false
false
United Kingdom
France
diphosphonates
treatment outcome
review of literature
french abstract
multiple myeloma

---
https://www.boitedecision.ulaval.ca/fileadmin/documents/Boites_PDF/Bisphosphonates/DBox_bisphosphonates_FR.pdf
2012
false
false
false
false
Canada
French
decision making
popular works
osteoporosis, postmenopausal
fractures, bone
diphosphonates
scientific and technical information

---
https://www.ema.europa.eu/medicines/human/EPAR/Aclasta
2012
United Kingdom
French
English
syndication feed
diphosphonates
imidazoles
bone density conservation agents
diphosphonates
imidazoles
bone density conservation agents
osteitis deformans
zoledronic acid
diphosphonates
imidazoles
osteoporosis, postmenopausal
osteoporosis
osteoporotic fractures
risk
hip fractures
osteoporosis
drug evaluation
summary of product characteristics
package leaflet
Zoledronic Acid
Zoledronic Acid

---
https://www.revmed.ch/RMS/2012/RMS-344/Fracture-atypique-du-femur-sous-bisphosphonates-un-effet-indesirable-a-ne-pas-manquer
2012
Switzerland
French
diphosphonates
femoral fractures
journal article

---
https://www.ema.europa.eu/medicines/human/EPAR/Ibandronic-Acid-Teva
2011
United Kingdom
French
English
syndication feed
fractures, bone
drug approval
pregnancy
drug interactions
breast feeding
treatment outcome
drug evaluation, preclinical
ibandronic acid
bone neoplasms
diphosphonates
diphosphonates
administration, oral
bone density conservation agents
bone density conservation agents
drugs, generic
osteoporosis, postmenopausal
diphosphonates
package leaflet
summary of product characteristics
drug evaluation
Ibandronic Acid
Ibandronic Acid

---
http://www.cbip.be/pdf/tft/TF_Osteop.pdf
2011
Belgium
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
osteoporosis
glucocorticoids
osteoporosis
treatment outcome
osteoporosis
bone density conservation agents
diphosphonates
alendronate
guideline

---
https://www.ema.europa.eu/medicines/human/EPAR/Bonviva
2011
United Kingdom
French
English
syndication feed
osteoporosis, postmenopausal
diphosphonates
diphosphonates
bone density conservation agents
bone density conservation agents
treatment outcome
drug evaluation
drug approval
drug labeling
injections, intravenous
administration, oral
spinal fractures
drug interactions
ibandronic acid
diphosphonates
drug evaluation
summary of product characteristics
package leaflet
Ibandronic Acid
Ibandronic Acid

---
https://www.ema.europa.eu/medicines/human/EPAR/Bondronat
2011
United Kingdom
French
English
syndication feed
bone resorption
drug approval
drug labeling
fractures, spontaneous
neoplasm metastasis
infusions, intravenous
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
diphosphonates
bone density conservation agents
hypercalcemia
breast neoplasms
bone neoplasms
diphosphonates
bone density conservation agents
treatment outcome
drug evaluation
ibandronic acid
diphosphonates
drug evaluation
summary of product characteristics
package leaflet
Ibandronic Acid
Ibandronic Acid

---
This medicine is now withdrawn from use in the European Union.
https://www.ema.europa.eu/medicines/human/EPAR/bondenza-previously-ibandronic-acid-roche
2011
false
United Kingdom
English
French
syndication feed
Contraindications, Procedure
food-drug interactions
drug interactions
pregnancy
breast feeding
diphosphonates
bone density conservation agents
diphosphonates
bone density conservation agents
renal insufficiency
diphosphonates
bone density conservation agents
drug labeling
osteoporosis, postmenopausal
diphosphonates
diphosphonates
diphosphonates
bone density conservation agents
bone density conservation agents
bone density conservation agents
treatment outcome
drug evaluation
tablets
administration, oral
injections, intravenous
fractures, bone
diphosphonates
bone density conservation agents
adult
aged
diphosphonates
bone density conservation agents
drug evaluation, preclinical
drug approval
ibandronic acid
diphosphonates
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug
Ibandronic Acid

---
http://www.cochrane.org/fr/CD009144
2011
false
true
false
United Kingdom
France
diphosphonates
review of literature
french abstract
osteoporosis
liver cirrhosis, biliary

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-01/skelid_14_12_2011_avis_ct11514.pdf
http://www.has-sante.fr/portail/jcms/c_399344/skelid-200-mg-comprime-boite-de-28
http://www.has-sante.fr/portail/jcms/c_456575/skelid
http://www.has-sante.fr/portail/jcms/c_1189028/skelid
2011
France
French
evaluation of the transparency committee
tiludronic acid
tiludronate disodium
bone density conservation agents
administration, oral
insurance, health, reimbursement
diphosphonates
osteitis deformans
tiludronic acid

---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/13569a-fra.php
2011
false
Canada
English
French
pharmacovigilance note
Risedronic Acid
hemipenta hydrate risedronate monosodium
etidronic acid
imidazoles
diphosphonates
osteoporosis
osteoporosis
femoral fractures
rare diseases
bisphosphonates
alendronate
bone density conservation agents
risk
alendronate sodium
Zoledronic Acid

---
https://www.ema.europa.eu/medicines/human/EPAR/Ibandronic-acid-Sandoz
2011
United Kingdom
French
English
summary of product characteristics
package leaflet
drug evaluation
syndication feed
drug approval
treatment outcome
diphosphonates
diphosphonates
drugs, generic
administration, oral
bone density conservation agents
bone density conservation agents
bone neoplasms
fractures, bone
breast neoplasms
neoplasm metastasis
ibandronic acid
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Ibandronic Acid
Ibandronic Acid

---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/13441a-fra.php
2010
Canada
English
French
bisphosphonates
femoral fractures
bone density conservation agents
diphosphonates
osteoporosis
pharmacovigilance note

---
http://www.cochrane.org/fr/CD005324
2010
United Kingdom
France
French
meta-analysis
osteoporosis
child
adolescent
diphosphonates
treatment outcome
bone density conservation agents
osteoporosis
french abstract

---
http://www.cochrane.org/fr/CD006250
2010
false
true
false
France
United Kingdom
diphosphonates
treatment outcome
review of literature
french abstract
prostatic neoplasms

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2010.07259/
2010
false
Switzerland
French
Cancer Pain Management
Cancer Pain
Cancer Pain
Cancer pain
diphosphonates
bone density conservation agents
bone neoplasms
bone neoplasms
pain
journal article
practice guideline

---
http://www.cochrane.org/fr/CD001347
2010
United Kingdom
France
French
Adrenocortical steroid therapy
corticosteroid therapy
meta-analysis
osteoporosis
adrenal cortex hormones
osteoporosis
diphosphonates
treatment outcome
bone density conservation agents
osteoporosis
french abstract

---
http://www.has-sante.fr/portail/jcms/c_994257/medronate-draximage
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-10/medronate_draximage_-_ct-_8639.pdf
2010
France
French
methylene diphosphonate
diphosphonates
bone diseases
adult
infant, newborn
child
adolescent
aged
technetium tc 99m medronate
technetium (99mtc) medronic acid
radiopharmaceuticals
diphosphonates
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/bonviva_-_ct-8848.pdf
http://www.has-sante.fr/portail/jcms/c_1032343/bonviva-acide-ibandronique-bisphosphonate
2010
France
French
administration, oral
injections
diphosphonates
bone density conservation agents
ibandronic acid
femoral neck fractures
insurance, health, reimbursement
osteoporosis, postmenopausal
treatment outcome
diphosphates
bone density conservation agents
spinal fractures
diphosphonates
diphosphonates
evaluation of the transparency committee
guidelines for drug use
Ibandronic Acid
Ibandronic Acid

---
http://www.has-sante.fr/portail/jcms/c_1016646/aredia
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/aredia_-_ct-_8294.pdf
2010
France
French
pamidronic acid
diphosphonates
bone density conservation agents
diphosphonates
evaluation of the transparency committee
Pamidronate

---
http://www.has-sante.fr/portail/jcms/c_813445/aclasta-acide-zoledronique-bisphosphonate-par-voie-iv
http://www.has-sante.fr/portail/jcms/c_799087/aclasta-ct-6147
2009
France
French
osteoporosis, postmenopausal
osteoporosis
bone density conservation agents
diphosphonates
imidazoles
injections, intravenous
zoledronic acid
diphosphonates
imidazoles
guidelines for drug use
evaluation of the transparency committee
Zoledronic Acid

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F36F01I
2009
Belgium
Dutch
French
diphosphonates
pain
aged
journal article
pharmacovigilance note

---
https://www.pharmacoclin.ch/_library/pdf/2009_36_1.pdf
2009
Switzerland
French
diphosphonates
bone density conservation agents
osteonecrosis
jaw diseases
osteoporosis
risk factors
diphosphonates
bone density conservation agents
femoral fractures
fractures, spontaneous
fractures, stress
time
journal article

---
http://www.mbcb-journal.org/articles/mbcb/abs/2008/01/mbcb2008141p5/mbcb2008141p5.html
10.1051/mbcb/2008015
2008
false
France
French
Osteonecrosis caused by drug (disorder)
osteonecrosis
diphosphonates
bone density conservation agents
maxillary diseases
journal article

---
http://www.meddispar.fr/medicaments/3687960
2008
France
French
diphosphonates
drug monitoring
pharmaceutical solutions
continuity of patient care
drug prescriptions
legislation, drug
infusions, intravenous
pamidronic acid
drug information
Pamidronate

---
http://www.meddispar.fr/medicaments/3687977
2008
France
French
diphosphonates
pharmaceutical solutions
infusions, intravenous
drug monitoring
continuity of patient care
drug prescriptions
legislation, drug
pamidronic acid
drug information
Pamidronate

---
http://www.meddispar.fr/medicaments/3688008
2008
France
French
diphosphonates
pharmaceutical solutions
infusions, intravenous
continuity of patient care
drug monitoring
drug prescriptions
legislation, drug
pamidronic acid
drug information
Pamidronate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68419617
2008
France
French
diphosphonates
administration, oral
tablets
ibandronic acid
drug information
Ibandronic Acid

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63460631
2008
France
French
diphosphonates
pharmaceutical solutions
injections, intravenous
ibandronic acid
drug information
Ibandronic Acid

---
http://www.meddispar.fr/medicaments/3688020
2008
France
French
diphosphonates
infusions, parenteral
drug monitoring
continuity of patient care
drug prescriptions
legislation, drug
pamidronic acid
drug information

---
http://www.meddispar.fr/medicaments/3634857
2008
France
French
diphosphonates
legislation, drug
bone density conservation agents
drug prescriptions
continuity of patient care
drug monitoring
infusions, parenteral
ibandronic acid
drug information
Ibandronic Acid

---
http://www.meddispar.fr/medicaments/3658711
2008
France
French
imidazoles
drug prescriptions
legislation, drug
diphosphonates
continuity of patient care
infusions, parenteral
zoledronic acid
drug information
Zoledronic Acid

---
https://www.has-sante.fr/jcms/r_1439939
2008
true
France
French
diphosphonates
imidazoles
bone density conservation agents
osteoporosis, postmenopausal
injections, intravenous
zoledronic acid
guidelines for drug use
Zoledronic Acid
Zoledronic Acid

---
https://cadth.ca/sites/default/files/cdr/complete/cdr_complete_Aclasta_july-08_f.pdf
2008
Canada
French
bone density conservation agents
diphosphonates
imidazoles
osteoporosis, postmenopausal
canada
treatment outcome
osteitis deformans
fractures, bone
infusions, intravenous
insurance, health, reimbursement
drug costs
zoledronic acid
diphosphonates
imidazoles
drug evaluation
Zoledronic Acid

---
https://minerva-ebp.be/fr/article/588
2007
false
minerva-ebm.be
Belgium
French
osteoporosis, postmenopausal
imidazoles
diphosphonates
imidazoles
diphosphonates
fractures, bone
drug evaluation
diphosphonates
imidazoles
critical appraisal or critical reading
Zoledronic Acid

---
http://revmed.ch/RMS/2007/RMS-112/32270
2007
Switzerland
French
diphosphonates
bone neoplasms
bone neoplasms
neoplasm metastasis
osteonecrosis
jaw diseases
diphosphonates
bone density conservation agents
journal article
drug information

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2007.06187/
2007
false
Switzerland
French
Osteonecrosis caused by drug (disorder)
bone density conservation agents
maxillary diseases
diphosphonates
osteonecrosis
osteonecrosis
osteonecrosis
journal article
image

---
https://www.cadth.ca/sites/default/files/pdf/301_teriparatide_tr_appendices_f.pdf
https://www.cadth.ca/fr/analyse-clinique-et-economique-du-teriparatide-et-des-bisphosphonates-dans-le-traitement-de
2006
true
Canada
French
teriparatide
bone density conservation agents
diphosphonates
osteoporosis, postmenopausal
bisphosphonates
teriparatide
drug evaluation
economic evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_400998
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct_2781_bonviva_ang.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/bonviva.pdf
2006
France
French
English
tablets
diphosphonates
bone density conservation agents
administration, oral
insurance, health, reimbursement
osteoporosis, postmenopausal
spinal fractures
treatment outcome
ibandronic acid
diphosphonates
evaluation of the transparency committee
Ibandronic Acid

---
https://www.cadth.ca/sites/default/files/pdf/371_bisphosphonates_tr_f.pdf
https://www.cadth.ca/fr/meta-analyse-des-bisphosphonates-dans-la-prevention-primaire-et-la-prevention-secondaire-des
2006
true
Canada
French
Risedronic Acid
bone density conservation agents
diphosphonates
osteoporosis, postmenopausal
alendronate
fractures, bone
fractures, bone
economics, pharmaceutical
bisphosphonates
meta-analysis
economic evaluation
drug evaluation

---
https://rmlg.uliege.be/article/1495
2006
Belgium
French
drug administration schedule
bone density conservation agents
diphosphonates
bone density conservation agents
osteoporosis, postmenopausal
medication adherence
diphosphonates
journal article
Ibandronic Acid

---
http://www.has-sante.fr/portail/display.jsp?id=c_468572
2006
France
French
syringes
pharmaceutical solutions
diphosphonates
bone density conservation agents
injections, intravenous
osteoporosis, postmenopausal
spinal fractures
insurance, health, reimbursement
treatment outcome
bone density conservation agents
diphosphonates
ibandronic acid
diphosphonates
evaluation of the transparency committee
Ibandronic Acid
Ibandronic Acid

---
http://revmed.ch/RMS/2005/RMS-39/30731
2005
false
Switzerland
French
Osteonecrosis caused by drug (disorder)
bone density conservation agents
diphosphonates
osteonecrosis
jaw diseases
drug monitoring
continuity of patient care
risk factors
drug interactions
review literature as topic
drug therapy, combination
journal article
drug information

---
https://www.amub-ulb.be/system/files/rmb/old/216
2005
Belgium
French
osteitis deformans
diphosphonates
imidazoles
bone density conservation agents
diphosphonates
imidazoles
journal article
Zoledronic Acid

---
http://revmed.ch/RMS/2005/RMS-35/30674
2005
Switzerland
French
osteoporosis
diphosphonates
treatment outcome
fractures, bone
bone density conservation agents
estrogens
drug therapy, combination
bone resorption
bisphosphonates
drug information
journal article
comparative study

---
https://www.cadth.ca/sites/default/files/pdf/170_bisphosphonate_tr_f.pdf
https://www.cadth.ca/fr/etude-methodique-de-lefficacite-pratique-et-de-linnocuite-des-bisphosphonates-dans-la-maitrise-de-la
2004
true
Canada
French
Cancer Pain Management
health technology assessment
table
french abstract
comparative study
Cancer Pain
bone neoplasms
diphosphonates
bibliography of medicine
pain
pain measurement
clinical trials as topic
clodronic acid
etidronic acid
treatment outcome
Cost-Benefit analysis
canada
morphine
analgesics
diphosphonates
diphosphonates
diphosphonates
Cancer Pain
Cancer pain

---
http://www.cmaj.ca/cgi/reprint/168/6_suppl/SF1.pdf
2003
Canada
French
canada
osteoporosis
osteoporosis
risk factors
population characteristics
aged
osteoporosis, postmenopausal
bone density
risk assessment
age factors
fractures, spontaneous
age distribution
sex distribution
accidental falls
osteoporosis
osteoporosis, postmenopausal
prednisone
osteoporosis
osteoporosis, postmenopausal
fractures, bone
densitometry
densitometry
predictive value of tests
continuity of patient care
spinal fractures
bone remodeling
Biomarkers
osteoporosis
osteoporosis
osteoporosis, postmenopausal
osteoporosis, postmenopausal
spinal fractures
diphosphonates
diphosphonates
calcitonin
calcitonin
calcitonin
administration, intranasal
hormone replacement therapy
menopause
premenopause
hormone replacement therapy
Raloxifene Hydrochloride
Raloxifene Hydrochloride
estrogen antagonists
estrogen antagonists
complementary therapies
vitamin K
isoflavones
fluorine
fluorine
diet
parathyroid hormone
exercise
child
algorithms
fractures, spontaneous
fractures, spontaneous
adult
middle aged
absorptiometry, photon
absorptiometry, photon
Evidence-Based medicine
practice guideline
journal article
osteoporosis
spinal fractures
fractures, bone
osteoporosis, postmenopausal

---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/bdc/e-docs/00/03/FD/F0/resume.md?type=text.html
2003
France
French
Cancer Pain Management
Cancer Pain
diphosphonates
pain
neoplasm metastasis
breast neoplasms
bone neoplasms
quality of life
bone neoplasms
drug evaluation
treatment outcome
clinical trials as topic
analgesics
Cancer Pain
Cancer pain
journal article
table

---
http://www.has-sante.fr/portail/display.jsp?id=c_399839
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031408.pdf
2003
France
French
diphosphonates
insurance, health, reimbursement
bone density conservation agents
infusions, intravenous
antineoplastic agents
pamidronic acid
hypercalcemia
osteitis deformans
multiple myeloma
osteolysis
diphosphonates
evaluation of the transparency committee
hypercalcemia
neoplasms
Pamidronate

---
https://ansm.sante.fr/uploads/2021/03/11/a7335ff84e05050e5dfccc7a164c885b.pdf
2002
false
France
French
diagnostic uses of chemicals
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
megestrol acetate
benzodiazepines
diphosphonates
glucocorticoids
medroxyprogesterone
morphine
antipsychotic agents
octreotide
Scopolamine
terminal care
benzodiazepines
benzodiazepines
benzodiazepines
benzodiazepines
benzodiazepines
randomized controlled trials as topic
diphosphonates
morphine
morphine
morphine
morphine
morphine
antipsychotic agents
antipsychotic agents
antipsychotic agents
antipsychotic agents
antipsychotic agents
octreotide
octreotide
octreotide
octreotide
octreotide
medroxyprogesterone
medroxyprogesterone
medroxyprogesterone
medroxyprogesterone
medroxyprogesterone
diphosphonates
diphosphonates
diphosphonates
diphosphonates
glucocorticoids
glucocorticoids
glucocorticoids
glucocorticoids
glucocorticoids
megestrol acetate
megestrol acetate
megestrol acetate
megestrol acetate
megestrol acetate
Scopolamine
Scopolamine
Scopolamine
Scopolamine
Scopolamine
adrenal cortex hormones
adrenal cortex hormones
adrenal cortex hormones
adrenal cortex hormones
adrenal cortex hormones
intestinal obstruction
pain
dyspnea
Evidence-Based medicine
terminally ill
practice guideline

---
https://www.cochrane.org/fr/CD002068/bisphosphonates-pour-le-soulagement-de-la-douleur-secondaire-aux-metastases-osseuses
2002
false
true
false
United Kingdom
France
diphosphonates
treatment outcome
Cancer Pain
review of literature
french abstract
neoplasm metastasis
pain

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.